1991 (2) TMI 63 - HC - Income Tax

Summary

Issues involved: Determination of whether the assessee was a manufacturer of the articles in question and whether the assessee could be treated as an 'industrial company' for tax purposes.

Manufacturing Activity Analysis:
The assessee initially manufactured pharmaceutical goods with its own plant and machinery, later transferring them to an associate company for manufacturing. Subsequently, the assessee resumed manufacturing with its own facilities during the relevant assessment year. The assessee maintained control over the manufacturing process, including quality control, when utilizing the services of the associate company. The court emphasized that the assessee's engagement in manufacturing activities was evident.

Legal Precedents and Interpretation:
Referring to the case of CIT v. Neo Pharma Private Ltd., the court highlighted that a company could be considered engaged in manufacturing goods even if it utilized another company for manufacturing under its supervision or control. The court noted that direct supervision by the assessee over the manufacturing process was not a strict requirement for classification as a manufacturing company.

Judgment and Conclusion:
The court agreed with the Tribunal's view that the assessee qualified as an industrial company engaged in manufacturing activities. It was deemed sufficient that the assessee was the actual manufacturer, even if it did not directly supervise the manufacturing process or pay the workers' wages. Citing the precedent and factual analysis, the court answered both questions in the affirmative and in favor of the assessee, leading to a decision without costs.